We are live on ! Find out more
WIM

Woodford Investment Management Portfolio holdings

AUM $310M
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
+4.42%
1 Year Est. Return
-17.41%
3 Year Est. Return
-27.14%
5 Year Est. Return
+68.29%
10 Year Est. Return
–
AUM
$1.24B
AUM Growth
+$82.6M
Cap. Flow
+$71M
Cap. Flow %
5.73%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
6
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
TBPH icon
Theravance Biopharma
TBPH
+$27M
2
BIIB icon
Biogen
BIIB
+$23.1M
3
NCNA
NuCana
NCNA
+$18.9M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$13.8M
5
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
+$7.04M

Top Sells

Rank Stock Value
1
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
+$22.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUTL
1
Autolus Therapeutics
AUTL
$562M
$379M 30.59%
12,041,419
+116,000
+1% +$3.3M
TBPH icon
2
Theravance Biopharma
TBPH
$877M
$303M 24.48%
13,379,979
+1,063,450
+9% +$27M
AGIO icon
3
Agios Pharmaceuticals
AGIO
$1.93B
$149M 12.06%
2,214,459
+237,000
+12% +$13.8M
PRTA icon
4
Prothena Corp
PRTA
$450M
$145M 11.68%
11,924,614
– –
ALKS icon
5
Alkermes
ALKS
$8.25B
$96.3M 7.78%
2,639,676
– –
BIIB icon
6
Biogen
BIIB
$30.7B
$70.9M 5.73%
300,040
+73,476
+32% +$23.1M
NCNA
7
NuCana
NCNA
$6.12M
$54.9M 4.43%
646
+273
+73% +$18.9M
EVFM
8
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$40.4M 3.26%
769,582
+130,036
+20% +$7.04M
NITE
9
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
– –
-1,921,315
Closed -$22.1M

Similar funds

LCM
Lucha Capital Management San Francisco, California $327M AUM 2.87% 1-Year Est. Return
GWA
Guidant Wealth Advisors Palatine, Illinois $269M AUM 2.79% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
IPC
Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return
AEPG
American Economic Planning Group Warren, New Jersey $367M AUM 2.51% 1-Year Est. Return
AR
Argyll Research Wilmington, Delaware $377M AUM 4.86% 1-Year Est. Return
KCM
Keywise Capital Management Grand Cayman, Cayman Islands $220M AUM 21.27% 1-Year Est. Return
COI
Capital One Investing Mclean, Virginia $430M AUM 3.49% 1-Year Est. Return

Woodford Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, Woodford Investment Management held 9 positions worth $1.24B, up 7.1% from $1.16B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Woodford Investment Management deployed $71M of net new capital in Q1 2019, adding to 6 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the most notable exit was Nightstar Therapeutics plc American Depositary Shares, an estimated $22.1M sold.

  • Woodford Investment Management added most to Theravance Biopharma in Q1 2019, an estimated $27M increase.
  • Woodford Investment Management fully exited Nightstar Therapeutics plc American Depositary Shares in Q1 2019, selling an estimated $22.1M.
  • Woodford Investment Management's ten largest holdings make up 100% of its $1.24B portfolio in Q1 2019.
  • Woodford Investment Management opened 0 new positions and closed 1 in Q1 2019.
  • Woodford Investment Management's portfolio value rose 7.1% quarter-over-quarter to $1.24B.

Based on Woodford Investment Management's 13F filing for Q1 2019, filed 14 May 2019.